1)Brinton LA, et al : Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 176 : 572─579, 1997
2)Yoshikawa H, et al : Prevalence of endometriosis in ovarian cancer. Gynecol Obstet Invest 50 : 11─17, 2000
3)Stern RC, et al : Malignancy in endometriosis : frequency and comparison of ovarian and extraovarian types. Int J Gynecol Pathol 20 : 133─139, 2001
4)小畑幸四郎 : 第55回日本産婦人科学会シンポジウム2.子宮内膜症のストラテジー.日本産婦人科学会誌55 : 890─902, 2003
5)小林 浩 : 子宮内膜症から発生する卵巣腫瘍の診断と治療.産婦人科の実際53 : 879─885, 2004
6)Mol BWJ, et al : The performance of CA125 measurement in the detection of endometriosis : a meta─analysis. Fertil Steril 70 : 1101─1108, 1998
7)Chen FP, et al : The use of serum CA125 as a marker for endometriosis in patients with dysmenorrhea for monitoring therapy and for recurrence of endometriosis. Acta Obstet Gynecol Scand 77 : 665─670, 1998
8)Malkasian GD, et al : Preoperative evaluation of serum CA125 levels in premenopausal and postmenopausal patients with pelvic masses : discrimination of benign from malignant disease. Am J Obstet Gynecol 159 : 341─346, 1988
9)Giudice LC, et al : Serum levels of CA125 in patients with endometriosis : preliminary report. Fertil Steril 45 : 876─878, 1986
10)Johansson J, et al : Explosive rise of serum CA125 following the rupture of ovarian endometrioma. Hum Repro 13 : 3503─3504, 1998
11)Rulin MC, et al : Adnexal masses in postmenopausal women. Obstet Gynecol 70 : 578─581, 1987
12)Tagashira Y, et al : Ovarian endometrioid adenocarcinoma arising from endometriosis in a young woman. Gynecol Oncol 91 : 643─647, 2003